People with Parkinson’s disease who combine standard medication with various types of acupuncture treatments may see improvements in their motor function and quality of life, a review study from China suggests. However, its researchers noted that additional clinical trials are necessary to validate these findings. The study, “Acupuncture-Related…

The mesencephalic locomotor region, a brain region previously thought to control only walking and other forms of locomotion in vertebrates, also regulates postural changes and other movements, according to a study in mice. “It was surprising that within this region, which everybody has linked to locomotion, many of the neurons…

My sister Bev, who has stage 3 Parkinson’s disease (PD), has always been an animal lover. I asked her to share with me how her pets have helped her through her illnesses. “I’ve had dogs and cats all of my life and always considered them great and loving friends,…

Inhibikase Therapeutics has received clearance from the U.S. Food and Drug Administration (FDA) to start a Phase 1 clinical trial evaluating its investigational, once-daily, oral medicine IkT-148009 in patients with Parkinson’s disease. The clearance comes after the agency reviewed the safety, tolerability and pharmacokinetic data from a Phase 1 study…

Parkinson’s vaccine candidate Affitope PD01, along with maker Affiris’ portfolio of other alpha-synuclein-targeting therapies, was acquired by AC Immune in a recent deal valued at nearly $60 million. “We believe very strongly that active vaccination will play an important role in the long-term management and possible prevention of…

Hypertension, or high blood pressure, almost doubles the risk of developing Parkinson’s disease in people of Han Chinese descent living in Singapore, a case-controlled study found. In contrast, a comparison of similar studies conducted in the U.S. and the U.K. found that hypertension was associated with a reduced risk…